Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HOXA7 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HOXA7 mRNA | CTD | PMID:24058054 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Hoxa7 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HOXA7 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of HOXA7 mRNA | CTD | PMID:21570461 | 2,6-dinitrotoluene | affects expression | ISO | Hoxa7 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of HOXA7 mRNA | CTD | PMID:21346803 | 2-palmitoylglycerol | increases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of HOXA7 mRNA | CTD | PMID:37199045 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | HOXA7 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HOXA7 mRNA | CTD | PMID:28628672 | 8'-apo-beta,psi-caroten-8'-al | increases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | apocarotenal results in increased expression of HOXA7 mRNA | CTD | PMID:17034753 | all-trans-retinoic acid | increases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of HOXA7 mRNA | CTD | PMID:17185360 | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [bisphenol F co-treated with Tretinoin] results in decreased expression of HOXA7 mRNA | CTD | PMID:30951980 | all-trans-retinoic acid | affects expression | EXP | | 6480464 | Tretinoin affects the expression of HOXA7 mRNA | CTD | PMID:14708090 | benzalkonium chloride | decreases expression | EXP | | 6480464 | Benzalkonium Compounds results in decreased expression of HOXA7 mRNA | CTD | PMID:30171875 | benzo[a]pyrene | increases methylation | ISO | HOXA7 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of HOXA7 3' UTR and Benzo(a)pyrene results in increased methylation of HOXA7 exon | CTD | PMID:27901495 | beta-carotene | increases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | beta Carotene results in increased expression of HOXA7 mRNA | CTD | PMID:17034753 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of HOXA7 mRNA | CTD | PMID:32156529 | bisphenol F | multiple interactions | ISO | HOXA7 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HOXA7 mRNA | CTD | PMID:28628672 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol F co-treated with Tretinoin] results in decreased expression of HOXA7 mRNA | CTD | PMID:30951980 | cadmium atom | increases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | Cadmium results in increased expression of HOXA7 mRNA | CTD | PMID:24376830 | cadmium atom | multiple interactions | ISO | HOXA7 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HOXA7 mRNA | CTD | PMID:35301059 | cadmium atom | decreases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | Cadmium results in decreased expression of HOXA7 mRNA | CTD | PMID:24284285 | cadmium dichloride | decreases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of HOXA7 mRNA | CTD | PMID:26472689 | cadmium dichloride | multiple interactions | ISO | HOXA7 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HOXA7 mRNA | CTD | PMID:35301059 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlordecone | increases expression | EXP | | 6480464 | Chlordecone results in increased expression of HOXA7 mRNA | CTD | PMID:33711761 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HOXA7 gene | CTD | PMID:20938992 | ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of HOXA7 mRNA | CTD | PMID:18353800 | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos and Crocidolite results in decreased expression of HOXA7 mRNA | CTD | PMID:29279043 | deoxynivalenol | increases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | deoxynivalenol results in increased expression of HOXA7 mRNA | CTD | PMID:19438726 | deoxynivalenol | multiple interactions | ISO | HOXA7 (Homo sapiens) | 6480464 | AG 1879 inhibits the reaction [deoxynivalenol results in increased expression of HOXA7 mRNA] | CTD | PMID:19438726 | dexamethasone | multiple interactions | ISO | HOXA7 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HOXA7 mRNA | CTD | PMID:28628672 | folic acid | multiple interactions | EXP | | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of HOXA7 mRNA | CTD | PMID:25629700 | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of HOXA7 mRNA | CTD | PMID:32186404 | gentamycin | decreases expression | ISO | Hoxa7 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of HOXA7 mRNA | CTD | PMID:33387578 | hydrogen peroxide | affects expression | ISO | HOXA7 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of HOXA7 mRNA | CTD | PMID:20044591 | indometacin | multiple interactions | ISO | HOXA7 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HOXA7 mRNA | CTD | PMID:28628672 | iron dichloride | decreases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of HOXA7 mRNA | CTD | PMID:35984750 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HOXA7 gene | CTD | PMID:20938992 | lipopolysaccharide | decreases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of HOXA7 mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | ISO | HOXA7 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HOXA7 mRNA | CTD | PMID:35811015 | nickel atom | decreases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | Nickel results in decreased expression of HOXA7 mRNA | CTD | PMID:24768652 and PMID:25583101 | paracetamol | decreases expression | ISO | Hoxa7 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of HOXA7 mRNA | CTD | PMID:33387578 | phenobarbital | decreases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | Phenobarbital results in decreased expression of HOXA7 mRNA | CTD | PMID:19084549 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | HOXA7 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HOXA7 mRNA | CTD | PMID:35811015 | silver atom | decreases expression | EXP | | 6480464 | Silver results in decreased expression of HOXA7 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | EXP | | 6480464 | Silver results in decreased expression of HOXA7 mRNA | CTD | PMID:27131904 | testosterone enanthate | affects expression | ISO | HOXA7 (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of HOXA7 mRNA | CTD | PMID:17440010 | titanium dioxide | affects expression | EXP | | 6480464 | titanium dioxide affects the expression of HOXA7 mRNA | CTD | PMID:23557971 | tremolite asbestos | decreases expression | EXP | | 6480464 | tremolite results in decreased expression of HOXA7 mRNA | CTD | PMID:29279043 | triptonide | decreases expression | EXP | | 6480464 | triptonide results in decreased expression of HOXA7 mRNA | CTD | PMID:33045310 | valproic acid | increases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of HOXA7 mRNA | CTD | PMID:23179753 | vitamin E | decreases expression | ISO | HOXA7 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of HOXA7 mRNA | CTD | PMID:19244175 | |